Christopher Jako - Brainsway President, Chief Executive Officer
| BWAY Stock | ILA 960.00 5.10 0.53% |
CEO
Christopher Jako is President, Chief Executive Officer of Brainsway since 2020.
| Age | 54 |
| Tenure | 4 years |
| Phone | (972) 2 582 4030 |
| Web | www.brainsway.com |
Brainsway Management Efficiency
The company has return on total asset (ROA) of (0.0751) % which means that it has lost $0.0751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2021) %, meaning that it generated substantial loss on money invested by shareholders. Brainsway's management efficiency ratios could be used to measure how well Brainsway manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | CEO Age | ||
| David Kutas | Bio View | 67 | |
| Alan Schwebel | Bio View | 69 | |
| Yuval Harari | Bio View | 53 | |
| Asher Zamir | Intercure | 44 | |
| Amy Kamin | Endymed | 56 | |
| Alexander Rabinovitch | Intercure | 52 | |
| Yosef BarOn | Endymed | 47 | |
| Elad Magal | Endymed | 59 | |
| Yoram Hert | Endymed | 53 | |
Management Performance
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 |
Brainsway Leadership Team
Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Avner Lushi, Director | ||
| Gavriel Magen, Director | ||
| Rami Itselev, Internal Auditor | ||
| Karen Sarid, Director | ||
| Moria Ankri, VP RD | ||
| Hila Rubinshtein, Managing Director of Quality Control | ||
| Menachem Esq, Gen VP | ||
| Hadar Levy, Senior Vice President, General Manager of North America | ||
| Richard Areglado, VP CFO | ||
| Christopher Jako, President, Chief Executive Officer | ||
| Uri Elmaliach, Director | ||
| Abraham Zangen, Director | ||
| Daniel Azriel, Director | ||
| David Zacut, Chairman of the Board, Interim Chief Executive Officer | ||
| Ety Rayten, External Director | ||
| Pr Zangen, Member CoFounder | ||
| Amit Jino, Clinical Experiment Coordinator | ||
| Yosef Shalom, Director | ||
| Avner Hagai, Co-Chairman of the Board | ||
| Christopher Boyer, Vice President - Global Marketing | ||
| Yiftach Roth, Chief Scientific Officer | ||
| Aron Tendler, Chief Officer | ||
| Ronen Segal, Vice President - Research & Development | ||
| Orly Uri, Director | ||
| Judith Huber, Chief Financial Officer, Senior Vice President |
Brainsway Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.29) % | |||
| Current Valuation | (85.93 M) | |||
| Shares Outstanding | 33.08 M | |||
| Shares Owned By Insiders | 19.83 % | |||
| Shares Owned By Institutions | 1.11 % | |||
| Price To Book | 0.65 X | |||
| Price To Sales | 3.76 X |
Pair Trading with Brainsway
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainsway position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will appreciate offsetting losses from the drop in the long position's value.Moving together with Brainsway Stock
| 0.76 | EPIT | Epitomee Medical | PairCorr |
Moving against Brainsway Stock
| 0.75 | INCR | Intercure | PairCorr |
| 0.61 | ISRA | Isramco Negev 2 | PairCorr |
| 0.52 | SOFW | Sofwave Medical | PairCorr |
The ability to find closely correlated positions to Brainsway could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainsway when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainsway - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainsway to buy it.
The correlation of Brainsway is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainsway moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainsway moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainsway can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |